EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Mitochondrial Metabolic Reprogramming: Reversing CD8⁺ T Cell Exhaustion and Improving Cancer Immunotherapy Response

Gang Liu, Jia Wang, Alena Mikalaeuna Vasiukevich, Biao Feng, Liqiang An

Biology and Medical Engineering · 18.09.2026 · 2 (1) · 1-35

DOI: 10.63808/bm.v2i1.531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology and Medical Engineering, online erschienen am 18.09.2026. Verfasst von Gang Liu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the reversal effect of targeting mitochondrial metabolic reprogramming on CD8⁺ T cell exhaustion within the tumor microenvironment and its synergistic mechanism when combined with immune checkpoint blockade therapy. B16-OVA melanoma and LLC lung cancer tumor-bearing mouse models were established. Using single-cell RNA sequencing, metabolic flux analysis, Seahorse cellular energy metabolism assay, and flow cytometry, we compared the mitochondrial function, metabolic characteristics, and exhaustion phenotypes of tumor-infiltrating CD8⁺ T cells with CD8⁺ T cells from the spleen/draining lymph nodes. By pharmacologically activating or overexpressing genes to intervene in the PGC-1α-mediated mitochondrial biogenesis pathway, we evaluated CD8⁺ T cell mitochondrial membrane potential, ROS levels, ATP production, oxygen consumption rate, and the ability to secrete IFN-γ, TNF-α, and Granzyme B. Further, combined treatment with anti-PD-1 was applied to observe tumor growth, survival, and the composition of tumor-infiltrating lymphocytes. Tumor-infiltrating CD8⁺ T cells exhibited reduced mitochondrial membrane potential, accumulated ROS, decreased oxygen consumption rate and ATP production, and showed increased expression of PD-1, TIM-3, LAG-3, and TOX, suggesting that metabolic dysfunction is closely related to T cell exhaustion. Targeting mitochondrial metabolic reprogramming can restore mitochondrial adaptability of CD8⁺ T cells, enhance their proliferation, cytokine secretion, and cytotoxicity, while reducing expression of exhaustion-associated molecules. The combination of this intervention with anti-PD-1 antibody significantly inhibited tumor growth, extended survival in tumor-bearing mice, and increased the proportion of stem-like/effector memory CD8⁺ T cells in tumors. Mitochondrial metabolic reprogramming is a key regulatory node for reversing CD8⁺ T cell exhaustion. Targeting this pathway can remodel the tumor immune microenvironment and enhance the response to immune checkpoint therapy, providing a potential new strategy for cancer immunotherapy.

Zitieren

APA

Liu, G., Wang, J., Vasiukevich, A. M., Feng, B., & An, L. (2026). Targeting Mitochondrial Metabolic Reprogramming: Reversing CD8⁺ T Cell Exhaustion and Improving Cancer Immunotherapy Response. Biology and Medical Engineering, 2(1), 1-35. https://doi.org/10.63808/bm.v2i1.531

Vancouver

Liu G, Wang J, Vasiukevich AM, Feng B, An L. Targeting Mitochondrial Metabolic Reprogramming: Reversing CD8⁺ T Cell Exhaustion and Improving Cancer Immunotherapy Response. Biology and Medical Engineering. 2026;2(1):1-35. doi:10.63808/bm.v2i1.531

BibTeX
@article{Liu2026,
  author = {Liu, Gang and Wang, Jia and Vasiukevich, Alena Mikalaeuna and Feng, Biao and An, Liqiang},
  title = {Targeting Mitochondrial Metabolic Reprogramming: Reversing CD8⁺ T Cell Exhaustion and Improving Cancer Immunotherapy Response},
  journal = {Biology and Medical Engineering},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {1--35},
  doi = {10.63808/bm.v2i1.531}
}
Kostenlos starten →